From owner-7tms_r@net.bio.net Thu Aug 01 23:00:00 1996
Path: biosci!OCELOT.RUTGERS.EDU!PDU
From: PDU@OCELOT.RUTGERS.EDU
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: MS Chemists Wanted
Date: 2 Aug 1996 05:58:02 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01I7SM5T8ZM88Y4Y2C@mbcl.rutgers.edu>
NNTP-Posting-Host: net.bio.net

Dear All,

Synaptic Pharmaceutical has multiple openings for chemists with
Master's degree in synthetic organic chemistry.  Experience with
HPLC, automated lab equipment, and computer data analysis would
be helpful.  Interested persons please send CV to the following
address or this email address.

Dr. Mohammad Mazarbadi
Department of Chemistry
Synaptic Pharmaceutical Corporation
215 College Road
Paramus, NJ 07652

From owner-7tms_r@net.bio.net Sun Aug 04 23:00:00 1996
Path: biosci!daresbury!not-for-mail
From: vijay@bmc.uu.se (Vijay Chhajlani)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Receptor:G-proteins
Date: 5 Aug 1996 08:56:58 +0100
Lines: 13
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <4u49ga$1s8@mserv1.dl.ac.uk>
X-Sender: vijay@bio.embnet.se
Original-To: 7tms_r@dl.ac.uk

Does any one know of a compiled list dscribing the different G protein
coupled receptors and the corresponding G proteins.
If I rceive partial lists, I will compile them and post.

Vijay Chhajlani                                 Tel: +46 18 17 4103/4930
Associate Professor
                                                Fax: +46 18 501920
Pharmaceutical Pharmacology Division
Biomedical Centre, Box 591,
Uppsala 751 24
sweden



From owner-7tms_r@net.bio.net Mon Aug 05 23:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!cssun.mathcs.emory.edu!news.service.emory.edu!news
From: KPM <kminneman@pharm.emory.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Is anybody using two hybrid system for specificity of receptor coupling to alpha subunits?
Date: Tue, 06 Aug 1996 14:49:12 -0700
Organization: Emory University
Lines: 7
Message-ID: <3207BDD8.BFE@pharm.emory.edu>
NNTP-Posting-Host: minnpc.pharm.emory.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.0 (Win16; I)

Has anyone tried the yeast two hybrid system for examining the 
specificity of coupling of GPCRs to alpha subunits?  I would appreciate 
any references and/or experience anyone has had in this area.

Thanks

Ken Minneman

From owner-7tms_r@net.bio.net Mon Aug 05 23:00:00 1996
Path: biosci!biosci!not-for-mail
From: a.c.noorlandt@chem.ruu.nl (Albert Noorlandt)
Newsgroups: bionet.biophysics,bionet.cellbiol,bionet.immunology,bionet.metabolic-reg,bionet.molbio.ageing,bionet.molbio.methds-reagnts,bionet.molbio.proteins,bionet.molbio.proteins.7tms_r,alt.med,alt.pharm,sci.bio.misc,sci.chem,sci.chem.analytical,sci.med,sci.misc,sci.techniques
Subject: 1997 FEBS Meeting on Cell Signalling Mechanisms
Date: 6 Aug 1996 17:24:42 -0700
Organization: CBLE
Lines: 29
Sender: biohelp@net.bio.net
Distribution: world
Message-ID: <a.c.noorlandt-0608961446360001@cble89.chem.ruu.nl>
NNTP-Posting-Host: net.bio.net
Xref: biosci bionet.biophysics:2198 bionet.cellbiol:5225 bionet.immunology:9491 bionet.metabolic-reg:805 bionet.molbio.ageing:2916 bionet.molbio.methds-reagnts:47700 bionet.molbio.proteins:8451 bionet.molbio.proteins.7tms_r:804 sci.bio.misc:4117 sci.chem:61653 sci.chem.analytical:5118 sci.med:133749 sci.misc:12601

FEBS Special Meeting on
Cell Signalling Mechanisms, From membrane to nucleus
Amsterdam, The Netherlands, June 29­July 3, 1997

Everything you want to know about this meeting on www-page:

   http://www.cble.chem.ruu.nl/febs97/index.html

The meeting will cover the following topics:
€  Tyrosine kinases
€  MAP-, Ser/Thr-kinases
€  G-coupled receptors
€  Lymphokine receptors
€  Ras, Rac, Rho-proteins
€  Ca2+, cGMP, NO
€  Lipid signalling
€  Steroid receptors
€  Transcription factors
€  Cell cycle, Apoptosis

For further information contact:
Secretariat FEBS Special Meeting 1997
Lidy Groot Congress Events
P.O. Box 83005
1080 AA Amsterdam
The Netherlands
Tel. +31.20.679 3218
Fax: +31.20.675 8236
Email: lidy.groot@inter.nl.net

From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!daresbury!not-for-mail
From: "Freddy de Bree" <bree@rabbit>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: N-glycosylation
Date: 8 Aug 1996 15:07:29 +0100
Lines: 12
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <4ucsb1$hfp@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

Dear Harm (Beste Harm),

To my knowledge the cannabinoid receptor is also devoid of a glycosylation
signal and can be expressed in Sf cells and is endogenously expressed in NG108
neuroblastoma cells (if the name is correct).

Regards,

Freddy De Bree
Protein Structure Group
Dept Chemistry
University of York

From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!bms.com!watson_j
From: watson_j@bms.com (John Watson)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: N-linked glycosylation
Date: 8 Aug 1996 06:38:49 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 40
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v01530500ae2f99f0151a@[140.176.107.223]>
NNTP-Posting-Host: net.bio.net

Harm van Heerikhuizen (vheerik@chem.vu.nl( wrote:

>Dear netters,
>
>We have recently cloned a GPCR that seems not to contain any consensus
>sites for N-linked glycosylation in its extracellular domains.
>A large body of published data indicates that N-linked glycosylation is
>important for proper routing and high-level expression of GPCRs.
>However, despite the fact that our receptor cannot be glycosylated it is
>expressed at high levels in HEK293 cells.
>
>Is anyone aware of any other GPCR (published or unpublished) that is also
>devoid of N-linked glycosylation?


The alpha2b adrenergic has been so reported (Weinshank et al. 1990 Mol.
Pharm. 38:681-688; Lomansey et al. 1990 PNAS 87:5094-5098), as has an
orphan melatonin-related receptor (Reppert et al., 1996 FEBS Lett.
386:219-224).

Cheers,

AJW


------------------------------------------------------------------------

    __ __ __       A. John Watson, Ph.D.
  /__/__/__/\      Bristol-Myers Squibb Company
 /__/__/__/\/\     Pharmaceutical Reseach Institute
/__/__/__/\/\/\    CNS Molecular Biology, Dept. 405
\__\__\__\/\/\/    5 Research Parkway
 \__\__\__\/\/     Wallingford, CT 06492
  \__\__\__\/
                   watson_j@bms.com      |
                   203.284.6745 voice    |  Standard Disclaimers Apply
                   203.284.7569 fax      |
------------------------------------------------------------------------



From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!war.wyeth.com!hadcocj
From: hadcocj@war.wyeth.com (John Hadcock)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: N-linked glycosylation -Reply
Date: 8 Aug 1996 06:03:35 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 14
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <s209ae30.020@war.wyeth.com>
NNTP-Posting-Host: net.bio.net

Harm
The human alpha2b-adrenergic receptor does not contain any consensus
sequences for N-linked glycosylation. Also, we truncated the rat
somatostatin receptor subtype 2 which removes all putative
N-glycosylation sites in the extracellular domains. We found that the
receptor is still expressed in high amounts with pharmacology
indistinguishable from the wild-type receptor. Also work from
Lefkowitz's and Malbon's labs many years ago reported that N-linked
glycosylation of the beta2-adrenergic receptor may not be critical
for proper routing of this receptor.
John Hadcock
Wyeth-Ayerst Reseearch
hadcocj@war.wyeth.com


From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!CHEM.VU.NL!vheerik
From: vheerik@CHEM.VU.NL (Harm van Heerikhuizen)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: N-linked glycosylation
Date: 8 Aug 1996 04:07:47 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 21
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v01540b00ae2f912e3252@[130.37.144.226]>
NNTP-Posting-Host: net.bio.net

Dear netters,

We have recently cloned a GPCR that seems not to contain any consensus
sites for N-linked glycosylation in its extracellular domains.
A large body of published data indicates that N-linked glycosylation is
important for proper routing and high-level expression of GPCRs.
However, despite the fact that our receptor cannot be glycosylated it is
expressed at high levels in HEK293 cells.

Is anyone aware of any other GPCR (published or unpublished) that is also
devoid of N-linked glycosylation?

Thanks

Harm van Heerikhuizen
Molecular Neurobiology group
Dept. of Biochemistry & Mol. Biol.
Vrije Universiteit, Amsterdam
The Netherlands



From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!Gems.VCU.EDU!DPETTIT
From: DPETTIT@Gems.VCU.EDU
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: glycosylation
Date: 8 Aug 1996 09:18:32 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 31
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01I816JZRY4I929QD0@Gems.VCU.EDU>
NNTP-Posting-Host: net.bio.net

Original-To: 7tms_r@dl.ac.uk

Dear Harm (Beste Harm),

To my knowledge the cannabinoid receptor is also devoid of a glycosylation
signal and can be expressed in Sf cells and is endogenously expressed in NG108
neuroblastoma cells (if the name is correct).

Regards,

Freddy De Bree
Protein Structure Group
Dept Chemistry
University of York


Dear Dr. De Bree,
     The neural cannabinoid receptor (CB1) has three potential glycosylation
sites (Matsuda et al. Nature Vol 346:561-564) in the extracellular amine
terminus.  It is thought that only two of these sites are actually glycosylated.
For more detailed information see: Chao Song and Allyn C. Howlett "Rat brain
cannabinoid receptors are n-linked glycosylated proteins", Life Science 
Vol 56:1983-1995.
     As for the peripheral cannabinoid receptor (CB2), there is one potential
glycosylation site in the extracellular amine terminus.  I don't know of 
any studies that have addressed it's use.

Regards,

Denise Pettit
Medical College of Virginia

From owner-7tms_r@net.bio.net Wed Aug 07 23:00:00 1996
Path: biosci!daresbury!not-for-mail
From: leurs@chem.vu.nl (Rob Leurs)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: TSH receptor
Date: 8 Aug 1996 11:04:49 +0100
Lines: 19
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <4uce41$fr@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

I am looking for the TSH receptor cDNA and the Graves IgG receptor
autoantibodies. Can someone supply us with these items? Your help is
appreciated!

Rob

******************************************************************************
Rob Leurs, Ph.D
Leiden/Amsterdam Center for Drug Research
Division of Medicinal Chemistry
Department of Pharmacochemistry, Vrije Universiteit
De Boelelaan 1083, 1081 HV Amsterdam
the Netherlands

fax: 31204447610
tel: 31204447579
leurs@chem.vu.nl



From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!agate!newsxfer2.itd.umich.edu!howland.erols.net!newsserver.jvnc.net!netnews.sbphrd.com!steven_mcclue-1
From: steven_mcclue-1@sbphrd.com (Steve McClue)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Receptor:G-proteins
Date: Fri, 09 Aug 1996 11:49:10 +0000
Organization: SB Pharmaceuticals
Lines: 18
Distribution: bionet
Message-ID: <steven_mcclue-1-0908961149100001@netnews.sbphrd.com>
References: <4u49ga$1s8@mserv1.dl.ac.uk>
NNTP-Posting-Host: ham992.ha.uk.sbphrd.com
X-Newsreader: Yet Another NewsWatcher 2.2.0b6

In article <4u49ga$1s8@mserv1.dl.ac.uk>, vijay@bmc.uu.se (Vijay Chhajlani)
wrote:

> Does any one know of a compiled list dscribing the different G protein
> coupled receptors and the corresponding G proteins.
> If I rceive partial lists, I will compile them and post.
> 
> Vijay Chhajlani                                 Tel: +46 18 17 4103/4930

There's a long list (probably a bit out of date now) which would be a good
place to start
in the monster review by Lutz Birnbaumer in Biochem Biophys Acta 1031
(1990) 163-224.

Steve

-- 
My opinions, not my employer's.

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!daresbury!not-for-mail
From: Freddy de Bree <bree@yorvic.york.ac.uk>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: G protein
Date: 9 Aug 1996 16:09:44 +0100
Lines: 8
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <4ufkbo$h9f@mserv1.dl.ac.uk>
Original-To: 7tms_r@dl.ac.uk

> coupled receptors and the corresponding G proteins

Dear Vijay Chhajlani,

there is a nice book that reviews a awful lot of GPCRs and their G-prot.
It is available with Academic Press.

Freddy

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!ASPIRINE.U-STRASBG.FR!weill
From: weill@ASPIRINE.U-STRASBG.FR (Claire Weill)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: hmAChR
Date: 9 Aug 1996 00:43:37 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 14
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <320B085D.7786@pharma.u-strasbg.fr>
NNTP-Posting-Host: net.bio.net

For our research in muscarinic acetylcholine receptor pharmacology, 
we're looking for human m1 and/or m2 AChR cDNA. Is there any 
possibility to get/buy this DNA preferably included in a plasmid for 
expression in eucaryotic cells, from a company or a laboratory ?
Please contact us if you have any information.

Yours sincerely.

Claire Weill
Laboratoire de Chimie BioOrganique
CNRS URA 1386
STRASBOURG-FRANCE
TEL : 33-88-67-69-60
FAX : 33-88-67-88-91

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!daresbury!bioftp.unibas.ch!infobiogen.fr!pasteur.fr!jussieu.fr!univ-angers.fr!ciril.fr!u-strasbg.fr!mgpwmac2.u-strasbg.fr!weill
From: Claire Weill <weill@pharma.u-strasbg.fr>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: looking for hm1AChR cDNA
Date: 9 Aug 1996 09:41:16 GMT
Organization: Chimie Bioorganique
Lines: 16
Distribution: world
Message-ID: <4uf13s$gm1@news.u-strasbg.fr>
NNTP-Posting-Host: mgpwmac2.u-strasbg.fr
Mime-Version: 1.0
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: 8bit
X-Newsreader: Nuntius 2.0.4_PPC
X-XXMessage-ID: <AE30D3E83403544C@mgpwmac2.u-strasbg.fr>
X-XXDate: Fri, 9 Aug 1996 10:39:20 GMT

For our research in muscarinic acetylcholine receptor pharmacology, we're
looking for human m1 and/or m2 AChR cDNA. Is there any possibility to
get/buy this DNA preferably included in a plasmid for expression in
eucaryotic cells, from a company or a laboratory ?
Please contact us if you have any information.

Yours sincerely

Claire Weill
Laboratoire de Chimie Bioorganique
CNRS URA 1386
STRASBOURG
FRANCE
Tel : 33-88-67-69-60
Fax : 33-88-67-88-91
Email : weill@pharma.u-strasbg.fr

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!agate!howland.erols.net!usc!usenet
From: yongyang@scf.usc.edu (yongyang)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: test
Date: 9 Aug 1996 23:21:11 GMT
Organization: University of Southern California, Los Angeles, CA
Lines: 1
Sender: yongyang@socialwork-pc3.usc.edu
Message-ID: <4ugh57$b5a@usc.edu>
NNTP-Posting-Host: socialwork-pc3.usc.edu

testing

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!agate!howland.erols.net!usc!usenet
From: yongyang@scf.usc.edu (yongyang)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: testing
Date: 9 Aug 1996 23:23:23 GMT
Organization: University of Southern California, Los Angeles, CA
Lines: 1
Sender: yongyang@socialwork-pc3.usc.edu
Message-ID: <4ugh9b$b5a@usc.edu>
NNTP-Posting-Host: socialwork-pc3.usc.edu

dgddfdf

From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!bms.com!watson_j
From: watson_j@bms.com (John Watson)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: G protein
Date: 9 Aug 1996 10:51:08 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 18
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v01530501ae3121cf6a03@[140.176.107.223]>
NNTP-Posting-Host: net.bio.net

Freddy de Bree <bree@yorvic.york.ac.uk> wrote:

>> coupled receptors and the corresponding G proteins
>
>Dear Vijay Chhajlani,
>
>there is a nice book that reviews a awful lot of GPCRs and their G-prot.
>It is available with Academic Press.
>
>Freddy

He is refering to the _G_Protein Linked Receptor FactsBook_, by S. Watson
and S. Arkinstall (Academic Press, 1994).  I like it, too, though by now it
is out of date.

AJW



From owner-7tms_r@net.bio.net Thu Aug 08 23:00:00 1996
Path: biosci!UMDNJ.EDU!howells
From: howells@UMDNJ.EDU (Richard Howells)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: N-linked glycosylation (fwd)
Date: 9 Aug 1996 13:17:35 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 65
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199608092017.NAA22143@net.bio.net>
NNTP-Posting-Host: net.bio.net

Forwarded message:
> From howells@UMDNJ.EDU Fri Aug  9 16:09:08 EDT 1996
> From: Richard Howells <howells@UMDNJ.EDU>
> Subject: Re: N-linked glycosylation
> To: vheerik@chem.vu.nl (Harm van Heerikhuizen)
> Date: Fri, 9 Aug 1996 16:09:05 -0400 (EDT)
> Cc: howells@UMDNJ.EDU (Richard Howells)
> In-Reply-To: <v01540b00ae2f912e3252@[130.37.144.226]> from "Harm van
Heerikhuizen" at Aug 8, 96 04:07:47 am
> X-Mailer: ELM [version 2.4 PL25]
> Mime-Version: 1.0
> Content-Type: text/plain; charset=US-ASCII
> Content-Transfer-Encoding: 7bit
> Content-Length: 1557      
> 
> > 
> > Dear netters,
> > 
> > We have recently cloned a GPCR that seems not to contain any consensus
> > sites for N-linked glycosylation in its extracellular domains.
> > A large body of published data indicates that N-linked glycosylation is
> > important for proper routing and high-level expression of GPCRs.
> > However, despite the fact that our receptor cannot be glycosylated it is
> > expressed at high levels in HEK293 cells.
> > 
> > Is anyone aware of any other GPCR (published or unpublished) that is also
> > devoid of N-linked glycosylation?
> > 
> > Thanks
> > 
> > Harm van Heerikhuizen
> > Molecular Neurobiology group
> > Dept. of Biochemistry & Mol. Biol.
> > Vrije Universiteit, Amsterdam
> > The Netherlands
> > 
> > 
> Harm:
> 
> In response to your question, we have created a truncated form of the mu
> opioid receptor that lacks all N-linked glycosylation sites and this
receptor
> is expressed at high levels in HEK293 cells and binds ligand with normal
> affinity (Shahrestanifar et al., J. Biol. Chem. 271: 5505-5512, 1996). We
do
> not know whether the receptor is localized on the plasma membrane, since
we
> generally use a crude membrane preparation for binding studies. Thus,
although
> this is not a natural example of a non-glycosylated receptor, it is
expressed
> well. There are examples of naturally occuring receptors that lack
consensus
> N-linked glycosylation sites: human and rat alpha2B adrenergic receptors
and
> the adenosine A2 receptor.> 
> 
> Richard Howells
> Department of Biochemistry and Molecular Biology
> University of Medicine and Dentistry of New Jersey
> Newark, NJ USA
> > 
> 
> 


From owner-7tms_r@net.bio.net Sun Aug 11 23:00:00 1996
Path: biosci!internet!biosci!not-for-mail
From: biohelp (BIOSCI Administrator)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: BIOSCI/bionet miniFAQ & Fundraiser
Date: 12 Aug 1996 02:00:06 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 239
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199608120900.CAA20576@net.bio.net>
NNTP-Posting-Host: net.bio.net

(LAST REVISION: 30-JUL-95)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
--------------------------------------------------------
As of 10 December 1995, all BIOSCI/bionet full newsgroups are
accessible through the World Wide Web (WWW) at URL http://www.bio.net.
One can read and reply publicly or privately to both recent postings
and archived messages through one's Web browser if it is configured
properly to send e-mail.  Each newsgroup is equipped with its own WAIS
index.  The main BIOSCI home page also has access to the BIO-JOURNALS
Table of Contents database WAIS index and the BIOSCI user address
database described in another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
computer daresbury.ac.uk (also known as dl.ac.uk):
-------------------------------------------------

To subscribe and unsubscribe to/from the BIOSCI lists, you need to
specify the full USENET newsgroup name with "bionet-news." prepended.
The USENET newsgroup names are listed in the BIOSCI Information sheet
on the Web at http://www.bio.net/.  For the METHODS-AND-REAGENTS list
the USENET newsgroup name is bionet.molbio.methds-reagnts, thus the
appropriate commands are

    sub bionet-news.bionet.molbio.methds-reagnts

    unsub bionet-news.bionet.molbio.methds-reagnts

These commands are included in a message addressed to mxt@dl.ac.uk,
NOT to the newsgroup mailing addresses.  As usual, include the text in
the body of the message as text on the Subject: line is ignored.

To unsubscribe from all the lists at the UK node, use

    unsub bionet-news

Please note that if the address in the list is different than the one
in your mail message header, you will not be able to unsubscribe by
this method. If you have problems, please mail biosci@daresbury.ac.uk.


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net

From owner-7tms_r@net.bio.net Sun Aug 11 23:00:00 1996
Path: biosci!GUITAR.ROCKEFELLER.EDU!ilya
From: ilya@GUITAR.ROCKEFELLER.EDU (Ilya Vakser)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Announcement - protein docking program GRAMM
Date: 12 Aug 1996 15:44:48 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 93
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <320FB51A.59E2@guitar.rockefeller.edu>
NNTP-Posting-Host: net.bio.net

-----------
GRAMM v1.03
-----------

This note is to announce the availability of GRAMM (Global RAnge 
Molecular Matching) software. GRAMM is a program for protein docking. To 
predict the structure of a complex, it requires only the atomic 
coordinates of the two molecules (no information about the binding sites 
is needed). The program performs an exhaustive 6-dimensional search 
through the relative translations and rotations of the molecules. The 
molecular pairs may be: two proteins, a protein and a smaller compound, 
two transmembrane (TM) helices, etc. GRAMM may be used for high-
resolution molecules, for inaccurate structures (where only the gross 
structural features are known), in cases of large conformational 
changes, etc.

The Global Range Molecular Matching (GRAMM) methodology is an empirical 
approach to smoothing the intermolecular energy function by changing the 
range of the atom-atom potentials. The technique allows to locate the 
area of the global minimum of intermolecular energy for structures of 
different accuracy. The quality of the prediction depends on the 
accuracy of the structures. Thus, the docking of high-resolution 
structures with small conformational changes yields an accurate 
prediction, while the docking of ultralow-resolution structures will 
give only the gross features of the
complex.

_________________

I am making GRAMM publicly available following a number of requests from 
different labs. I would like to make it clear, however, that both the 
methodology and the program, at present, are in the process of active 
development and validation, especially in the area of the low-resolution 
docking, and have to be viewed like that. The program is free. However, 
I would expect proper references. I will also appreciate bug reports. To 
get GRAMM, send the request to ilya@guitar.rockefeller.edu. The GRAMM 
site on the Web is http://guitar.rockefeller.edu/. 

GRAMM was created during my stay in the Weizmann Institute (1991-1993), 
in the Washington University (1993-1995), and in the Rockefeller 
University (1995-1996). I deeply appreciate the assistance of my 
colleagues in all these institutions (especially, Profs. Ephraim 
Katchalski-Katzir, Garland Marshall, and Andrej Sali).

Platforms

Presently, GRAMM is compiled on SGI R4000, SGI R4400, SGI R8000, and SGI 
R10000 Unix workstations. In the near future I will expand this list, so 
check the GRAMM site for the updates. Interestingly, GRAMM also works on 
a PC platform under Windows95 (the performance on P5-120 with 16 MB RAM 
is only two times slower than on SGI 250 MHZ Indigo2 R4400).

Papers on GRAMM methodology

* E. Katchalski-Katzir, I. Shariv, M. Eisenstein, A. A. Friesem, C.
  Aflalo, I. A. Vakser, 1992, Molecular surface recognition:
  Determination of geometric fit between proteins and their ligands by
  correlation techniques, Proc. Natl. Acad. Sci. USA, 89, 2195-2199.
  (Basic algorithm of protein recognition by correlation technique with
  Fast Fourier transform. High-resolution 'geometric' docking).

* I. A. Vakser, C. Aflalo, 1994, Hydrophobic docking: A proposed
  enhancement to molecular recognition techniques, Proteins, 20,
  320-329. (High-resolution 'hydrophobic' docking).

* I. A. Vakser, G. V. Nikiforovich, 1995a, Protein docking in the
  absence of detailed molecular structures, in: Methods in Protein
  Structure Analysis (M. Z. Atassi & E. Appella, eds.), Plenum Press,
  New York, pp. 505-514.

* I. A. Vakser, 1995b, Protein docking for low-resolution structures,
  Protein Eng., 8, 371- 377. ('Low-resolution' protein docking).

* I. A. Vakser, 1996a, Long-distance potentials: An approach to the
  multiple-minima problem in ligand-receptor interaction, Protein Eng.,
  9, 37-41. (Interpretation of the low-resolution docking in terms of
  energy potentials).

* I. A. Vakser, 1996b, Low-resolution docking: Prediction of complexes
  for underdetermined structures, Biopolymers, in press (39, No.3).
  (Validation of the low-resolution docking).

* I. A. Vakser, 1996c, Main-chain complementarity in protein-protein
  recognition, Protein Eng., in press (9, No.7). (Docking of Ca
  structures).

------------------------------------------------------------------
Ilya A. Vakser
The Rockefeller University, Box 270
1230 York Avenue, New York, NY 10021
Phone: (212) 327-7206; Fax: (212) 327-7540
Email: ilya@guitar.rockefeller.edu
------------------------------------------------------------------

From owner-7tms_r@net.bio.net Mon Aug 12 23:00:00 1996
Path: biosci!rutgers!uwm.edu!news.moneng.mei.com!news.ecn.bgu.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!in3.uu.net!EU.net!main.Germany.EU.net!fu-berlin.de!news.dfn.de!news.embl-heidelberg.de!bioftp.unibas.ch!infobiogen.fr!pasteur.fr!univ-lyon1.fr!news-rocq.inria.fr!irisa.fr!univ-rennes1.fr!univ-angers.fr!ciril.fr!usenet
From: regnault@hemato.u-nancy.fr (Veronique REGNAULT)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: pI of streptokinase
Date: 13 Aug 1996 12:19:55 GMT
Organization: Hématologie, Faculté de Médecine, Nancy, France
Lines: 1
Message-ID: <4uprtb$3dk@arcturus.ciril.fr>
Reply-To: regnault@hemato.u-nancy.fr
NNTP-Posting-Host: micro5.hemato.u-nancy.fr
Mime-Version: 1.0
Content-Type: text/plain; charset=iso-8859-1
Content-Transfer-Encoding: 8bit
X-Newsreader: WinVN 0.92.6+

Hye, I am searching for the pI of streptokinase; Thanks very much to send the response to the above E-mail address.

From owner-7tms_r@net.bio.net Mon Aug 12 23:00:00 1996
Path: biosci!QM.SERVER.UFL.EDU!jkhlab
From: jkhlab@QM.SERVER.UFL.EDU ("JKHLab")
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: pI of streptokinase
Date: 13 Aug 1996 07:17:55 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 15
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <n1372190950.99487@qm.server.ufl.edu>
NNTP-Posting-Host: net.bio.net

        Reply to:   RE>pI of streptokinase

Hello,

The pI of the human isoform of streptokinase was shown to be 5.2 by Einarsson
M et al. Biochim Biophys Acta 1979;568:19-29 and confirmed by Nowicki et al
Thrombosis and Haemostasis 1994; 72:595-603.  Additionally, the equine isoform
was shown to have two isoforms with pI values of 5.5 and 5.7 as reported by
Nowicki et al.  I hope this helps.

Stephen Nowicki
University of Florida
College of Medicine
stn@icbr.ifas.ufl.edu


From owner-7tms_r@net.bio.net Tue Aug 13 23:00:00 1996
Path: biosci!UCDAVIS.EDU!mxkoolpe
From: mxkoolpe@UCDAVIS.EDU (Mitchell Koolpe)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 14 Aug 1996 11:08:50 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 3
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.GSO.3.95.960814110844.1071A-100000@chip.ucdavis.edu>
NNTP-Posting-Host: net.bio.net

subscribe mxkoolpe@ucdavis.edu



From owner-7tms_r@net.bio.net Mon Aug 19 23:00:00 1996
Path: biosci!rutgers!uwm.edu!news.cse.psu.edu!news.ecn.bgu.edu!vixen.cso.uiuc.edu!newsfeed.internetmci.com!in2.uu.net!EU.net!Norway.EU.net!nntp.uio.no!nntp.uib.no!nntp-bergen.UNINETT.no!nntp-trd.UNINETT.no!news.uit.no!atf1!edvard
From: edvard@imb.fm.uit.no (Oyvind Edvardsen)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Mutant database GRAP update
Date: 20 Aug 1996 12:03:39 GMT
Organization: University of Tromsoe
Lines: 50
Distribution: world
Message-ID: <4vc9ir$fqb@news.uit.no>
Reply-To: edvard@imb.fm.uit.no
NNTP-Posting-Host: atf1.imb.fm.uit.no


The mutant database GRAP has been updated. In the current update there
are no new mutant data added to GRAP. However, we work hard to provide
mutant data in the future as well. The current update is focused on new
access facilities to enhance the usefulness of the database and to exploit
the existing data as much as possible.

New functionality:
1) Complete list of papers referenced in the database, organized according
to receptor class.
2) Complete list of ligands organized according to receptor class and
agonist/antagonist classification.
3) The mutant lists (e.g. returned from a search for all substitutions in a
particular receptor domain) can have two different formats for multiple point
mutants.
4) All short format lists of mutants can be searched for n-fold change in
ligand binding.
5) The alignment was updated to enable searching for all mutants involving
substitution(s) at a particular alignment position.
6) The alignment was updated to enable searching for all mutants registered
for a single receptor.

Furthermore, there are certain other enhancements, changes, updates and
corrections. The database has also been moved to another server. However,
the address remains the same:
http://www-grap.fagmed.uit.no/GRAP/homepage.html

If you have problems with the new version of GRAP, you can still access the
original version on
http://atf1.imb.fm.uit.no/GRAP/homepage.html
(at least for some time).

The extended search facilities in GRAP were presented at the Nordic-Baltic
symposium on Heptahelix Receptors, August 15-16, Uppsala, Sweden.

-oed.

-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-o-
___                    _                     
| /|              _|  |_  _|     __   _  _|  _  _
|/_| \/ \/ | |\| |_|  |_ |_| \/ |_|_ |  |_| _\ |_' |\|
     /
_____________________________________________________________________________
School of Medicine               |
Dept. of Pharmacology, IMB       |  TelePhone: +47 77 64 53 42
University of Tromsoe            |  TeleFax: +47 77 64 53 10
MH, Breivika                     |  Email: edvard@fagmed.uit.no
N-9037 TROMSOE, NORWAY           |  URL: http://atf1.fagmed.uit.no/mgl.html
------------------------------------------------------------------------------


From owner-7tms_r@net.bio.net Tue Aug 20 23:00:00 1996
Path: biosci!VIOLET.INCM.U-NANCY.FR!poda
From: poda@VIOLET.INCM.U-NANCY.FR (Gennady PODA)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: (none)
Date: 21 Aug 1996 03:50:45 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 2
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.SGI.3.91.960821125120.2722A@violet.incm.u-nancy.fr>
NNTP-Posting-Host: net.bio.net

subscribe


From owner-7tms_r@net.bio.net Wed Aug 21 23:00:00 1996
Path: biosci!SUN.UCHC.EDU!hla
From: hla@SUN.UCHC.EDU (Timothy Hla)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 22 Aug 1996 08:38:11 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v01530501ae422f78d3dc@[155.37.2.192]>
NNTP-Posting-Host: net.bio.net

subscribe

Timothy Hla, PhD
Associate Professor
Department of Physiology, MC3505
University of Connecticut School of Medicine
263 Farmington Avenue
Farmington, CT 06030
ph: 860-679-4128
fx: 860-679-1269
e-mail: hla@sun.uchc.edu



From owner-7tms_r@net.bio.net Tue Aug 27 23:00:00 1996
Path: biosci!PHARMACOP.COM!vdfitz
From: vdfitz@PHARMACOP.COM (Dan Fitzpatrick)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 28 Aug 1996 05:12:52 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 11
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v02130500ae49af9b6a10@[198.138.203.138]>
NNTP-Posting-Host: net.bio.net



/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\
|   Dan Fitzpatrick, PhD        vdfitz@pharmacop.com
|   Pharmacopeia, Inc.          phone: 609-452-3715
|   Department of Biology      fax: 609-655-4187
|   3000 East Park Blvd.
|   Cranbury NJ  08512
\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/\/



From owner-7tms_r@net.bio.net Tue Aug 27 23:00:00 1996
Path: biosci!UH.EDU!Standifer
From: Standifer@UH.EDU (Kelly Standifer)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: recombinant adenylyl cyclases
Date: 28 Aug 1996 15:08:02 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 24
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01I8TEYV4IUK00140L@Post-Office.UH.EDU>
NNTP-Posting-Host: net.bio.net

Hi,
I've recently purchased some adenylyl cyclase antisera from Santa Cruz and
was wondering if recombinant adenylyl cyclase isoforms also were
commercially available for use as positive controls? I've had no success
locating any. Of course, I'd gladly accept free handouts!

Thanks in advance for your input,
Kelly



***************************************************************************
Kelly M. Standifer
Assistant Professor

Dept. Pharmacological and Pharmaceutical Sciences
University of Houston
4800 Calhoun
Houston, TX  77204-5515  USA
phone: 713-743-1771
fax:713-743-1229

"Madness takes its toll.....please have exact change.


From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!BAYOU.UH.EDU!sxn83991
From: sxn83991@BAYOU.UH.EDU (savitha)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: (none)
Date: 29 Aug 1996 21:06:21 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 2
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.OSF.3.93.960829230430.22658A-100000@Bayou.UH.EDU>
NNTP-Posting-Host: net.bio.net

subscribe


From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!BAYOU.UH.EDU!sxn83991
From: sxn83991@BAYOU.UH.EDU (savitha nagaraja)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: AccessUH Starting Point
Date: 29 Aug 1996 20:43:48 -0700
Organization: university of houston
Lines: 4
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01I8V4ZWYW6Y00140L@Post-Office.UH.EDU>
NNTP-Posting-Host: net.bio.net

subscribe




From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!mcsun!EU.net!howland.erols.net!cs.utexas.edu!swrinde!news.uh.edu!news.uth.tmc.edu!usenet
From: tblevins@gsbs3.gs.uth.tmc.edu (Tracy Blevins)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Hela cells and adenylycylase
Date: Thu, 29 Aug 96 15:13:33 PST
Organization: The University of Texas Houston Health Science Center
Lines: 13
Message-ID: <504tr9$q9p@oac2.hsc.uth.tmc.edu>
NNTP-Posting-Host: farmr7.med.uth.tmc.edu
Mime-Version: 1.0
X-Newsreader: WinVN 0.93.02

Hello,

I am looking for information about the Hela cell line.
        Specifically:
                1.  Does it express adenylylcylase (any type)?
                2.  Does it express G proteins?
                3.  Does it express beta 2 adrenergic receptors?

I would appreciate any information you might have on this topic.

Thanks,   Tracy Blevins



From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!BIOCSERVER.BIOC.CWRU.EDU!roth
From: roth@BIOCSERVER.BIOC.CWRU.EDU (Bryan Roth)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Santa Cruz antibodies
Date: 29 Aug 1996 09:34:59 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 22
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199608291635.QAA13610@biocserver.BIOC.CWRU.Edu>
NNTP-Posting-Host: net.bio.net

>In response to recent postings about Santa Cruz antibodies, I wonder
>if people would post their success, or lack of success, with these
>reagents.
>
>I have heard from a number of people who have had no success with 
>the antibodies they obtained.  Maybe an informal poll would be useful 
>in this forum.
>
>Ken Minneman


We've used  antibodies (Gq and Gq/G11) at both authentic recombinant Gq we 
prepared in the lab as well as against cell extracts.  Both antibodies 
behaved as advertised and are routinely used.

We've also used their anti-PKC subtype antibodies with good success.  

Caveat emptor though applies with all biological reagents--you always need 
to check out with authentic standards and do the appropriate controls.

Bryan Roth


From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!bms.com!watson_j
From: watson_j@bms.com (John Watson)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Santa Cruz antibodies
Date: 29 Aug 1996 08:35:18 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 39
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <v0153050fae4b62d39f55@[140.176.107.223]>
NNTP-Posting-Host: net.bio.net

Ken Minneman <kminneman@pharm.emory.EDU> wrote:

>In response to recent postings about Santa Cruz antibodies, I wonder
>if people would post their success, or lack of success, with these
>reagents.
>
>I have heard from a number of people who have had no success with
>the antibodies they obtained.  Maybe an informal poll would be useful
>in this forum.


I am testing two or three of their anti-G(alpha) antisera today.  I will be
glad to post the results of this little experiment, and I look forward to
other responses as well.

As an aside, it is my understanding that Santa Cruz normally ships sera at
ambient temperature, not on ice or frozen.  When I send home-grown sera
around, I always ship it frozen.  While I am not an antibody expert, I
wonder if some reports of failure with Santa Cruz sera could be due to
their preferred method of shipment.

AJW


------------------------------------------------------------------------

    __ __ __       A. John Watson, Ph.D.
  /__/__/__/\      Bristol-Myers Squibb Company
 /__/__/__/\/\     Pharmaceutical Reseach Institute
/__/__/__/\/\/\    CNS Molecular Biology, Dept. 405
\__\__\__\/\/\/    5 Research Parkway
 \__\__\__\/\/     Wallingford, CT 06492
  \__\__\__\/
                   watson_j@bms.com      |
                   203.284.6745 voice    |  Standard Disclaimers Apply
                   203.284.7569 fax      |
------------------------------------------------------------------------



From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!agate!spool.mu.edu!uwm.edu!cs.utexas.edu!swrinde!cssun.mathcs.emory.edu!news.service.emory.edu!news
From: KPM <kminneman@pharm.emory.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Santa Cruz antibodies
Date: Thu, 29 Aug 1996 09:21:36 -0700
Organization: Emory University
Lines: 9
Message-ID: <3225C390.7CAB@pharm.emory.edu>
NNTP-Posting-Host: minnpc.pharm.emory.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 3.0 (Win16; I)

In response to recent postings about Santa Cruz antibodies, I wonder
if people would post their success, or lack of success, with these
reagents.

I have heard from a number of people who have had no success with 
the antibodies they obtained.  Maybe an informal poll would be useful 
in this forum.

Ken Minneman

From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!mcsun!EU.net!howland.erols.net!swrinde!cssun.mathcs.emory.edu!news.service.emory.edu!news
From: TJ Murphy <medtjm@bimcore.emory.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Santa Cruz antibodies
Date: Thu, 29 Aug 1996 13:02:36 -0700
Organization: Emory University
Lines: 12
Message-ID: <3225F75C.10F2@bimcore.emory.edu>
References: <199608291635.QAA13610@biocserver.BIOC.CWRU.Edu>
NNTP-Posting-Host: murphy1.pharm.emory.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 2.0 (Win95; I; 16bit)

We've had very disappointing results in Westerns and immunohistochemistry 
with three of their anti-NFAT (anti-peptide) antibodies.

These antibodies were shipped on wet ice.
-- 

T.J. Murphy, Ph.D.
Assistant Professor
Department of Pharmacology                  404-727-2467
Emory University School of Medicine         404-727-0365 (fax)
5031 O.W. Rollins Research Building         medtjm@bimcore.emory.edu
Atlanta, GA 30322

From owner-7tms_r@net.bio.net Wed Aug 28 23:00:00 1996
Path: biosci!SPINE.MED.UTORONTO.CA!milton
From: milton@SPINE.MED.UTORONTO.CA (Milton Charlton)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Muscarinic receptors
Date: 29 Aug 1996 10:25:57 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 13
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.SUN.3.91.960829125655.8373D-100000@spine.med.utoronto.ca>
References: <v0153050fae4b62d39f55@[140.176.107.223]>
NNTP-Posting-Host: net.bio.net

Are there any cases of muscarinic Ca++ responses which can not be blocked 
by atropine or scopolamine?  With 1nM muscarine we get intracellular Ca 
release seen with fluo3 which can not be blocked with 20uM atropine.  O
Oxotremorine also gives Ca responses.  Specific nicotinic agonists and 
antagonists have no effect (nicotine, pancuronium, a-bungarotoxin, 
k-bungarotxin).  Gallamine, however, does block muscarinic Ca signals.
  This is in frog tissue.  Naturally we want to discover 
m6  |) but I guess there could be modifications of known receptors which 
could give these results.
Does anyone have suggestions on how to interpret this?
Thanks,
Milton Charlton


From owner-7tms_r@net.bio.net Thu Aug 29 23:00:00 1996
Path: biosci!PEAPLANT.BIOLOGY.YALE.EDU!staub
From: staub@PEAPLANT.BIOLOGY.YALE.EDU (Jeff Staub)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: subscribe
Date: 30 Aug 1996 14:36:47 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 10
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <32275E23.753C@peaplant.biology.yale.edu>
NNTP-Posting-Host: net.bio.net

subscribe
-- 
______________________________________________________________________

Jeffrey M. Staub	     Lab: (203) 432-8909
Yale University		     Fax: (203) 432-3854
Department of Biology	    
http://peaplant.biology.yale.edu:8001/denglab.html
OML 301
New Haven, CT 06520-8104

From owner-7tms_r@net.bio.net Thu Aug 29 23:00:00 1996
Path: biosci!bcm.tmc.edu!cs.utexas.edu!swrinde!cssun.mathcs.emory.edu!news.service.emory.edu!news
From: KPM <kminneman@pharm.emory.edu>
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: Re: Hela cells and adenylycylase
Date: Fri, 30 Aug 1996 10:58:44 -0700
Organization: Emory University
Lines: 20
Message-ID: <32272BD4.690@pharm.emory.edu>
References: <504tr9$q9p@oac2.hsc.uth.tmc.edu>
NNTP-Posting-Host: minnpc.pharm.emory.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 3.0 (Win16; I)

Tracy Blevins wrote:
> 
> Hello,
> 
> I am looking for information about the Hela cell line.
>         Specifically:
>                 1.  Does it express adenylylcylase (any type)?
>                 2.  Does it express G proteins?
>                 3.  Does it express beta 2 adrenergic receptors?
> 
> I would appreciate any information you might have on this topic.
> 
> Thanks,   Tracy Blevins


They have functional beta-2 receptors linked to cAMP accumulation.  Much
of this data is very old.  Check out PNAS 74: 873-877 (1977) by Tallman
et al.  The receptors can be induced with butyrate.  

Ken Minneman

From owner-7tms_r@net.bio.net Thu Aug 29 23:00:00 1996
Path: biosci!ulb.ac.be!swillens
From: swillens@ulb.ac.be (=?iso-8859-1?Q?St=E9phane?= Swillens)
Newsgroups: bionet.molbio.proteins.7tms_r
Subject: (none)
Date: 30 Aug 1996 01:03:41 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 7
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199608300802.KAA09045@resu1.ulb.ac.be>
NNTP-Posting-Host: net.bio.net

subscribe

St=E9phane Swillens
IRIBHN - Facult=E9 de M=E9decine
Universit=E9 Libre de Bruxelles
fax: 32-2-5554655


